78 related articles for article (PubMed ID: 1864765)
1. Mode of antibacterial action of cefprozil, a new cephalosporin, on Escherichia coli, Serratia marcescens and Morganella morganii.
Nishimoto K; Usui T; Miyake Y; Suginaka H
Hiroshima J Med Sci; 1991 Mar; 40(1):35-40. PubMed ID: 1864765
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic and clinical studies on cefprozil granules in the pediatric field].
Motohiro T; Aramaki M; Oda K; Kawakami A; Koga T; Tomita S; Sakata Y; Yamashita F; Takajo N; Okabayashi S
Jpn J Antibiot; 1992 Dec; 45(12):1700-35. PubMed ID: 1289589
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of a new cephalosporin, cefotaxime.
Russell AD; Rogers DT
J Appl Bacteriol; 1980 Aug; 49(1):137-41. PubMed ID: 6253429
[No Abstract] [Full Text] [Related]
4. beta-Lactam resistance in Serratia marcescens: comparison of action of benzylpenicillin, Apalcillin, Cefazolin, and ceftizoxime.
Takata N; Suginaka H; Kotani S; Ogawa M; Kosaki G
Antimicrob Agents Chemother; 1981 Mar; 19(3):397-401. PubMed ID: 7018390
[TBL] [Abstract][Full Text] [Related]
5. [Laboratory and clinical studies on cefprozil in the field of pediatrics].
Hayakawa F; Kuno K; Ogawa A; Nakao Y; Ando Y; Ando H
Jpn J Antibiot; 1992 Nov; 45(11):1558-70. PubMed ID: 1494237
[TBL] [Abstract][Full Text] [Related]
6. [Clinical studies on cefprozil granules in pediatric skin soft tissues infections].
Motohiro T; Aramaki M; Oda K; Kawakami A; Koga T; Tomita S; Sakata Y; Yamashita F; Tanaka K; Matsukuma Y
Jpn J Antibiot; 1992 Dec; 45(12):1684-99. PubMed ID: 1289588
[TBL] [Abstract][Full Text] [Related]
7. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
[TBL] [Abstract][Full Text] [Related]
8. The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
Neu HC; Chin NX; Labthavikul P
Chemioterapia; 1985 Dec; 4(6):415-23. PubMed ID: 3879464
[TBL] [Abstract][Full Text] [Related]
9. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
[TBL] [Abstract][Full Text] [Related]
10. Effect of 6059-S, a noval oxacephem, on cross-linking reaction of peptidoglycan biosynthesis in Escherichia coli, Pseudomonas aeruginosa and Serratia marcescens.
Takata N; Ogawa M; Kosaki G; Suginaka H
Arch Microbiol; 1981 Sep; 130(1):90-1. PubMed ID: 6458255
[No Abstract] [Full Text] [Related]
11. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
12. [The influence of cefprozil on intestinal bacterial flora].
Iwata S; Ikeda M; Yamada K; Isohata E; Kin Y; Kusumoto Y; Sato Y; Akita H; Nanri S; Oikawa T
Jpn J Antibiot; 1992 Nov; 45(11):1474-88. PubMed ID: 1494231
[TBL] [Abstract][Full Text] [Related]
13. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
[TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of oral cephalosporins (author's transl)].
Wiedemann B; Flensberg T
Infection; 1979; 7 Suppl 6():551-3. PubMed ID: 399247
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
Luh KT; Chao HP; Ho SW; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550
[TBL] [Abstract][Full Text] [Related]
16. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
Yoshida T; Tateda E; Hiramatsu K; Yokota T
Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of 6- and 7-[2-(5-carboxyimidazole-4-carboxamido)phenylacetamido]-penicillins and cephalosporins.
Yasuda N; Iwagami H; Nakanishi E; Nakamiya T; Sasaki Y; Murata T
J Antibiot (Tokyo); 1983 Mar; 36(3):242-9. PubMed ID: 6339459
[TBL] [Abstract][Full Text] [Related]
18. [Morphological studies on antibacterial activities of cefotiam (author's transl)].
Konno M; Ubukata K; Takahashi H; Sawai M; Saito K
Jpn J Antibiot; 1979 May; 32(5):583-97. PubMed ID: 379387
[TBL] [Abstract][Full Text] [Related]
19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activities of piperacillin alone and in combination with tazobactam against beta-lactamase-producing bacteria.
Chang SC; Hsu LY; Luh KT; Hsieh WC
J Formos Med Assoc; 1991 Oct; 90(10):947-52. PubMed ID: 1685175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
